Portfolio company
Apton Biosystems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Apton Biosystems develops high-throughput DNA sequencing and single-molecule detection systems for clinical researchers and laboratories performing large-scale genomic analysis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
CytoTerra
This company develops next-generation sequencing assays to detect chromosomal abnormalities for clinical researchers and healthcare providers specialising in oncology and genetic diseases.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Element Biosciences
Element Biosciences develops DNA sequencing platforms and multi-omics tools for researchers and diagnostic laboratories in the life sciences and genomics sectors.
Swift Biosciences
This company develops next-generation sequencing library preparation kits for researchers in academic, translational and clinical laboratories.
